After drug Approval

MIM Pharma is predicting a good year for the company, with several products in the pipeline and the potential migraine Spray EMA approval. We are pleased with the progress and the momentum that we’ve been able to make over the past couple of years, Our positive data from migraine patient’s treatments on a number of clinical trials make us very excited to launch the product in the European market during 2021 and help patients to get rid of their migraine headaches.